HEART SCAN NEWS
A recent report from Harvard Medical School says middle-aged andolder women need to worry about particular health concerns -osteoporosis, breast cancer, ovarian cancer and microvasculardisease, a type of heart disease more common in women.
A recent report from Harvard Medical School says middle-aged andolder women need to worry about particular health concerns -osteoporosis, breast cancer, ovarian cancer and microvasculardisease, a type of heart disease more common in women.
AP - Editors of a top medical journal call Meridia \"another flawed diet pill\" and question whether it should stay on the market as a study shows it raises the risk of heart attack and stroke in people with heart problems.
Overweight people with a history of heart disease who take the prescription weight-loss drug Meridia may be at increased risk of heart attack or stroke, according to a study published this week in the New England Journal of Medicine.
Abbott Laboratories’ weight loss pill Meridia increases the risk of heart attacks and strokes in people with existing heart disease, according to a study published in the New England Journal of Medicine.
The Pediatric Heart Transplant Program at NewYork-Presbyterian/Morgan Stanley Children’s Hospital is partnering with CareSpeak Communications to bring mHealth (mobile health) to its teenage heart transplant patients and their families. The CareSpeak system uses 2-way text messaging to ensure patients take their medications on time and as prescribed, significantly decreasing the likelihood of organ rejection due to medication non-adherence. The system\'s efficacy was demonstrated in research published in the November 2009 issues of Pediatrics.

The Pediatric Heart Transplant Program at NewYork-Presbyterian/Morgan Stanley Children’s Hospital is partnering with CareSpeak Communications to bring mHealth (mobile health) to its teenage heart transplant patients and their families. The CareSpeak system uses 2-way text messaging to ensure patients take their medications on time and as prescribed, significantly decreasing the likelihood of organ rejection due to medication non-adherence. The system\'s efficacy was demonstrated in research published in the November 2009 issues of Pediatrics.

The Pediatric Heart Transplant Program at NewYork-Presbyterian/Morgan Stanley Children’s Hospital is partnering with CareSpeak Communications to bring mHealth (mobile health) to its teenage heart transplant patients and their families. The CareSpeak system uses 2-way text messaging to ensure patients take their medications on time and as prescribed, significantly decreasing the likelihood of organ rejection due to medication non-adherence. The system\'s efficacy was demonstrated in research published in the November 2009 issues of Pediatrics.

The Pediatric Heart Transplant Program at NewYork-Presbyterian/Morgan Stanley Children’s Hospital is partnering with CareSpeak Communications to bring mHealth (mobile health) to its teenage heart transplant patients and their families. The CareSpeak system uses 2-way text messaging to ensure patients take their medications on time and as prescribed, significantly decreasing the likelihood of organ rejection due to medication non-adherence. The system\'s efficacy was demonstrated in research published in the November 2009 issues of Pediatrics.

The Pediatric Heart Transplant Program at NewYork-Presbyterian/Morgan Stanley Children’s Hospital is partnering with CareSpeak Communications to bring mHealth (mobile health) to its teenage heart transplant patients and their families. The CareSpeak system uses 2-way text messaging to ensure patients take their medications on time and as prescribed, significantly decreasing the likelihood of organ rejection due to medication non-adherence. The system\'s efficacy was demonstrated in research published in the November 2009 issues of Pediatrics.